Search results
Results from the WOW.Com Content Network
As Deputy Commissioner for Policy at FDA (1991–94), Taylor oversaw the development of biotechnology policies by FDA's Center for Food Safety and Applied Nutrition, including FDA's 1992 guidance on genetically modified (GM) foods and a guidance that milk from cows treated with bovine growth hormone (BGH did not have to be labeled as such). [44]
The United States commissioner of food and drugs is the head of the Food and Drug Administration (FDA), an agency of the United States Department of Health and Human Services. The commissioner is appointed by the president of the United States and must be confirmed by the Senate. The commissioner reports to the secretary of health and human ...
Cross-platform open-source desktop search engine. Unmaintained since 2011-06-02 [9]. LGPL v2 [10] Terrier Search Engine: Linux, Mac OS X, Unix: Desktop search for Windows, Mac OS X (Tiger), Unix/Linux. MPL v1.1 [11] Tracker: Linux, Unix: Open-source desktop search tool for Unix/Linux GPL v2 [12] Tropes Zoom: Windows: Semantic Search Engine (no ...
Syngenta rejecteded another unsolicited offer from Monsanto, worth $45 billion, with management saying it undervalued the company and a merger would carry significant risks. Monsanto offered to acquire the company at a price of 449 Swiss francs per Syngenta share, with approximately 45% of the price paid in cash. [29] [30] 19 2014
Robert McKinnon Califf (born 1951) is an American cardiologist who served as the 25th commissioner of food and drugs from 2016 to 2017 and again from 2022 to 2025.. He was first nominated to be commissioner in September 2015 by President Barack Obama [1] and he was confirmed by the U.S. Senate in February 2016, [2] serving until January 20, 2017.
The FDA approved aspartame's use in soft drinks in November 1983, and Pepsi was among the first brands to deploy the product on a large scale in the United States. When G. D. Searle was acquired by Monsanto in 1985, Shapiro moved up the management chain in the ladder, becoming Vice President in 1990, President in 1993 and CEO in 1995.
The search engine that helps you find exactly what you're looking for. Find the most relevant information, video, images, and answers from all across the Web. AOL.
Patrizia Cavazzoni was the director of the U.S. Food and Drug Administration's (FDA) Center for Drug Evaluation and Research (CDER). Prior to this position she worked at Pfizer and had been a psychiatrist. She resigned from FDA on January 10, 2025, ten days before Donald Trump took office. [3]